Upon receiving the appropriate activating signal, natural killer T (NKT) cells live up to their name, releasing a torrent of molecules that trigger the protective immune response necessary to eliminate pathogens or even thwart tumor growth.
These cells represent a promising clinical tool, as demonstrated in a recent clinical trial in which lung cancer patients received NKT-stimulating injections of dendritic cells that had been pretreated with á-galactosylceramide (á-GalCer)1. Some 60% of treated patients exhibited a striking seven-fold improvement in their median survival time relative to their untreated counterparts. “The effects are superior to other molecular-targeted cancer drugs,” says Masaru Taniguchi of the RIKEN Research Center for Allergy and Immunology (RCAI), Yokohama, whose team participated in this study. “However, this therapy is not applicable to two-thirds of patients because of their limited number of NKT cells.”
To solve this problem, Taniguchi teamed up with RCAI colleague Haruhiko Koseki to develop a method for generating transplantable NKTs2. They derived these from induced pluripotent stem cells (iPSCs), embryonic-like cells that are typically generated via virus-mediated delivery of ‘reprogramming genes’ into skin cells. However, NKT maturation involves a complex genomic rearrangement event, making them difficult to derive from conventional iPSCs. As such, Taniguchi and Koseki devised a novel approach for generating mouse iPSCs from existing NKTs, which have already undergone this rearrangement. They used these iPSCs to generate large numbers of new NKTs in vitro.
Their method efficiently produced mature NKTs, which rapidly established a stable population within the liver upon transplantation into mice. To the researchers’ pleasant surprise, these new NKTs displayed typical activation behavior in response to á-GalCer-treated dendritic cells and proved capable of coordinating an effective immune response. “In general, cells generated from in vitro culture die quickly in vivo or are killed by host immune cells … however, this was not the case here,” says Taniguchi. “We detected iPSC-derived NKT cells with adjuvant activity and tumor-eradicating effects two weeks after cell transfer.”
Taniguchi, Koseki and colleagues are now keen to begin working with human cells. This transition will involve many new challenges, but the researchers see great clinical potential in their approach—particularly in the US, where the Food and Drug Administration has approved development of cell-based therapies. “NKT cell-targeted adjuvant cell therapy is applicable [to] any type of cancer patient, because it can overcome [their] immunodeficient status and enhances antitumor responses,” says Taniguchi. “At present, the delivery of patient dendritic cells is the main limiting factor.”The corresponding author for this highlight is based at the Laboratory for Immune Regulation, RIKEN Research Center for Allergy and Immunology
Associated linksLink to article
2. 2.Watarai, H., Fujii, S., Yamada, D., Rybouchkin, A., Sakata, S., Nagata, Y., Iida-Kobayashi, M., Sekine-Kondo, E., Shimizu, K., Shozaki, Y. et al. Murine induced pluripotent stem cells can be derived from and differentiate into natural killer T cells. The Journal of Clinical Investigation 120, 2610–2618 (2010).
Further reports about: > Allergy > Creating > Immunology > Koseki > NKT > NKT cells > RCAI > RIKEN > T cells > Taniguchi > cancer drug > dendritic cells > human cell > immune cell > immune response > induced pluripotent stem > induced pluripotent stem cell > lung cancer > natural killer T > pluripotent stem cells > skin cell > stem cells
Scientists enlist engineered protein to battle the MERS virus
22.05.2017 | University of Toronto
Insight into enzyme's 3-D structure could cut biofuel costs
19.05.2017 | DOE/Los Alamos National Laboratory
Two-dimensional magnetic structures are regarded as a promising material for new types of data storage, since the magnetic properties of individual molecular building blocks can be investigated and modified. For the first time, researchers have now produced a wafer-thin ferrimagnet, in which molecules with different magnetic centers arrange themselves on a gold surface to form a checkerboard pattern. Scientists at the Swiss Nanoscience Institute at the University of Basel and the Paul Scherrer Institute published their findings in the journal Nature Communications.
Ferrimagnets are composed of two centers which are magnetized at different strengths and point in opposing directions. Two-dimensional, quasi-flat ferrimagnets...
An Australian-Chinese research team has created the world's thinnest hologram, paving the way towards the integration of 3D holography into everyday...
In the race to produce a quantum computer, a number of projects are seeking a way to create quantum bits -- or qubits -- that are stable, meaning they are not much affected by changes in their environment. This normally needs highly nonlinear non-dissipative elements capable of functioning at very low temperatures.
In pursuit of this goal, researchers at EPFL's Laboratory of Photonics and Quantum Measurements LPQM (STI/SB), have investigated a nonlinear graphene-based...
Dental plaque and the viscous brown slime in drainpipes are two familiar examples of bacterial biofilms. Removing such bacterial depositions from surfaces is...
For the first time, scientists have succeeded in studying the strength of hydrogen bonds in a single molecule using an atomic force microscope. Researchers from the University of Basel’s Swiss Nanoscience Institute network have reported the results in the journal Science Advances.
Hydrogen is the most common element in the universe and is an integral part of almost all organic compounds. Molecules and sections of macromolecules are...
22.05.2017 | Event News
17.05.2017 | Event News
16.05.2017 | Event News
22.05.2017 | Materials Sciences
22.05.2017 | Life Sciences
22.05.2017 | Physics and Astronomy